Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 611

    1.

    Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.

    Heald AH, Siddals KW, Fraser W, Taylor W, Kaushal K, Morris J, Young RJ, White A, Gibson JM.

    Diabetes. 2002 Aug;51(8):2629-36.PMID: 12145180 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects.

    Gibson JM, Westwood M, Lauszus FF, Klebe JG, Flyvbjerg A, White A.

    Diabetes. 1999 Feb;48(2):321-6.PMID: 10334308 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM).

    Gibson JM, Westwood M, Young RJ, White A.

    J Clin Endocrinol Metab. 1996 Feb;81(2):860-3.PMID: 8636318 [PubMed - indexed for MEDLINE]Related articles

    4.

    Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations.

    Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A, Sampayo J, Taylor W, Fraser W, White A, Gibson JM.

    Diabetologia. 2001 Mar;44(3):333-9.PMID: 11317665 [PubMed - indexed for MEDLINE]Related articles

    5.

    C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups.

    Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM, Cruickshank K.

    Atherosclerosis. 2003 Sep;170(1):79-86.PMID: 12957685 [PubMed - indexed for MEDLINE]Related articles

    6.

    Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.

    Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM.

    Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):371-6.PMID: 16915540 [PubMed - indexed for MEDLINE]Related articles

    7.

    IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants.

    Kajantie E, Dunkel L, Rutanen EM, Seppälä M, Koistinen R, Sarnesto A, Andersson S.

    J Clin Endocrinol Metab. 2002 May;87(5):2171-9.PMID: 11994360 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effect of maternal diabetes on phosphorylation of insulin-like growth factor binding protein-1 in cord serum.

    Loukovaara M, Leinonen P, Teramo K, Nurminen E, Andersson S, Rutanen EM.

    Diabet Med. 2005 Apr;22(4):434-9.PMID: 15787669 [PubMed - indexed for MEDLINE]Related articles

    9.

    Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.

    Jehle PM, Jehle DR, Mohan S, Böhm BO.

    J Endocrinol. 1998 Nov;159(2):297-306.PMID: 9795371 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.

    Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.

    Diabetes Metab Res Rev. 1999 Sep-Oct;15(5):314-22.PMID: 10585616 [PubMed - indexed for MEDLINE]Related articles

    12.

    Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome.

    Mohamed-Ali V, Pinkney JH, Panahloo A, Cwyfan-Hughes S, Holly JM, Yudkin JS.

    Clin Endocrinol (Oxf). 1999 Feb;50(2):221-8.PMID: 10396366 [PubMed - indexed for MEDLINE]Related articles

    13.

    Reduced IGFBP-1 is associated with thickening of the carotid wall in type 2 diabetes.

    Leinonen ES, Salonen JT, Salonen RM, Koistinen RA, Leinonen PJ, Sarna SS, Taskinen MR.

    Diabetes Care. 2002 Oct;25(10):1807-12.PMID: 12351482 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion.

    Shishko PI, Dreval AV, Abugova IA, Zajarny IU, Goncharov VC.

    Diabetes Res Clin Pract. 1994 Aug;25(1):1-12.PMID: 7530621 [PubMed - indexed for MEDLINE]Related articles

    16.

    Dietary intake and the insulin-like growth factor system: effects of migration in two related populations in India and Britain with markedly different dietary intake.

    Heald AH, Sharma R, Anderson SG, Vyas A, Siddals K, Patel J, Bhatnagar D, Prabharkaran D, Rudenski A, Hughes E, Durrington P, Gibson JM, Cruickshank JK.

    Public Health Nutr. 2005 Sep;8(6):620-7.PMID: 16236191 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.

    Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB.

    Int J Obes Relat Metab Disord. 1997 May;21(5):355-9.PMID: 9152736 [PubMed - indexed for MEDLINE]Related articles

    19.

    Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).

    López-Bermejo A, Khosravi J, Fernández-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gil MM, Rosenfeld RG, Ricart W.

    Diabetes. 2006 Aug;55(8):2333-9.PMID: 16873698 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Insulin-like growth factor binding protein production in bovine retinal endothelial cells.

    Giannini S, Cresci B, Manuelli C, Fujita-Yamaguchi Y, Romagnani P, Mohan S, Rotella CM.

    Metabolism. 1997 Dec;46(12):1367-79.PMID: 9439529 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data